Currency Exchange International, Corp.
CURN
$19.20
$0.050.26%
| Weiss Ratings | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.66 | |||
| Price History | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.16% | |||
| 30-Day Total Return | 3.59% | |||
| 60-Day Total Return | 5.28% | |||
| 90-Day Total Return | 4.46% | |||
| Year to Date Total Return | 2.35% | |||
| 1-Year Total Return | 2.18% | |||
| 2-Year Total Return | 36.86% | |||
| 3-Year Total Return | 62.20% | |||
| 5-Year Total Return | 1.35% | |||
| 52-Week High % Change | -4.96% | |||
| 52-Week Low % Change | 38.77% | |||
| Price | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $20.15 | |||
| 52-Week Low Price | $13.80 | |||
| 52-Week Low Price (Date) | Oct 26, 2023 | |||
| 52-Week High Price (Date) | Aug 08, 2023 | |||
| Valuation | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 125.00M | |||
| Enterprise Value | 28.22M | |||
| Price/Earnings (TTM) | 13.68 | |||
| Earnings Per Share (TTM) | 1.40 | |||
| Earnings Per Share Growth | -20.96% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.53 | |||
| Price/Book (Q) | 1.53 | |||
| Enterprise Value/Revenue (TTM) | 0.33 | |||
| Price | $18.75 | |||
| Enterprise Value/EBITDA (TTM) | 1.50 | |||
| Enterprise Value/EBIT | 1.60 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.68M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 407 240 0224 | |||
| Address | 6675 Westwood Boulevard Orlando, FL 32821 | |||
| Website | www.ceifx.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 20.33% | |||
| Profit Margin | 11.28% | |||
| Management Effectiveness | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.98% | |||
| Return on Equity | 12.44% | |||
| Income Statement | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 83.74M | |||
| Total Revenue (TTM) | 83.74M | |||
| Revenue Per Share | $12.54 | |||
| Gross Profit (TTM) | 82.72M | |||
| EBITDA (TTM) | 18.16M | |||
| EBIT (TTM) | 17.03M | |||
| Net Income (TTM) | 9.45M | |||
| Net Income Avl. to Common (TTM) | 9.45M | |||
| Total Revenue Growth (Q YOY) | 7.23% | |||
| Earnings Growth (Q YOY) | -46.53% | |||
| EPS Diluted (TTM) | 1.40 | |||
| EPS Diluted Growth (Q YOY) | -45.83% | |||
| Balance Sheet | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 105.82M | |||
| Cash Per Share (Q) | $15.84 | |||
| Total Current Assets (Q) | 121.60M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 80.52M | |||
| Current Ratio (Q) | 2.450 | |||
| Book Value Per Share (Q) | $12.48 | |||
| Total Assets (Q) | 133.78M | |||
| Total Current Liabilities (Q) | 49.64M | |||
| Total Debt (Q) | 7.00M | |||
| Total Liabilities (Q) | 53.26M | |||
| Total Common Equity (Q) | 80.52M | |||
| Cash Flow | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.34M | |||
| Cash from Financing (TTM) | -23.04M | |||
| Net Change in Cash (TTM) | 7.34M | |||
| Levered Free Cash Flow (TTM) | 31.53M | |||
| Cash from Operations (TTM) | 32.33M | |||
